ATE105865T1 - Erhöhte ausscheidung von heterologen proteinen durch wirtszellen durch verwendung von substituierten promotoren. - Google Patents
Erhöhte ausscheidung von heterologen proteinen durch wirtszellen durch verwendung von substituierten promotoren.Info
- Publication number
- ATE105865T1 ATE105865T1 AT86906826T AT86906826T ATE105865T1 AT E105865 T1 ATE105865 T1 AT E105865T1 AT 86906826 T AT86906826 T AT 86906826T AT 86906826 T AT86906826 T AT 86906826T AT E105865 T1 ATE105865 T1 AT E105865T1
- Authority
- AT
- Austria
- Prior art keywords
- dna
- heterologous proteins
- host cells
- promoters
- signal sequence
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 230000029142 excretion Effects 0.000 title 1
- 108010076504 Protein Sorting Signals Proteins 0.000 abstract 4
- 108020004414 DNA Proteins 0.000 abstract 3
- 102000007469 Actins Human genes 0.000 abstract 2
- 108010085238 Actins Proteins 0.000 abstract 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 abstract 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 abstract 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 2
- 230000028327 secretion Effects 0.000 abstract 2
- 229960000187 tissue plasminogen activator Drugs 0.000 abstract 2
- 102000003390 tumor necrosis factor Human genes 0.000 abstract 2
- 102100028991 Cytochrome c1, heme protein, mitochondrial Human genes 0.000 abstract 1
- 101000916041 Homo sapiens Cytochrome c1, heme protein, mitochondrial Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 101000947508 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Cytochrome c isoform 1 Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/69—Increasing the copy number of the vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Lubricants (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858529014A GB8529014D0 (en) | 1985-11-25 | 1985-11-25 | Enhanced secretion of heterologous proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE105865T1 true ATE105865T1 (de) | 1994-06-15 |
Family
ID=10588758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86906826T ATE105865T1 (de) | 1985-11-25 | 1986-11-24 | Erhöhte ausscheidung von heterologen proteinen durch wirtszellen durch verwendung von substituierten promotoren. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5082783A (de) |
| EP (1) | EP0283475B1 (de) |
| JP (2) | JP2528849B2 (de) |
| AT (1) | ATE105865T1 (de) |
| CA (1) | CA1318617C (de) |
| DE (1) | DE3689846T2 (de) |
| GB (1) | GB8529014D0 (de) |
| WO (1) | WO1987003300A1 (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0281246A3 (de) * | 1987-02-04 | 1989-07-12 | Invitron Corporation | Verfahren zur Erhöhung der Amplifikation und Expression fremder Gene |
| US5030563A (en) * | 1987-07-07 | 1991-07-09 | Genetics Institute, Inc. | Bacterial hypersecretion using mutant repressor sequence |
| ATE151110T1 (de) * | 1988-09-02 | 1997-04-15 | Protein Eng Corp | Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen |
| US5326700A (en) * | 1990-11-06 | 1994-07-05 | Eli Lilly And Company | DNA sequences encoding t-PA derivatives with cleavable sites |
| DE4107612A1 (de) * | 1991-03-09 | 1992-09-10 | Behringwerke Ag | Rekombinante proteine mit der immunreaktivitaet des hepatitis b virus e antigens (hbeag), verfahren zu ihrer herstellung und ihre verwendung in immunoassays und impfstoffen |
| US5298422A (en) * | 1991-11-06 | 1994-03-29 | Baylor College Of Medicine | Myogenic vector systems |
| US5925564A (en) * | 1991-11-06 | 1999-07-20 | Baylor College Of Medicine | Expression vector systems and method of use |
| WO1995016772A1 (en) | 1993-12-14 | 1995-06-22 | Cornell Research Foundation, Inc. | Adenovirus gene expression system |
| EP0822984A4 (de) | 1995-04-27 | 2000-05-03 | Human Genome Sciences Inc | Rezeptor für humanen tumor nekrosis faktor |
| US5925351A (en) * | 1995-07-21 | 1999-07-20 | Biogen, Inc. | Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| EP0878552A1 (de) * | 1997-05-13 | 1998-11-18 | Erasmus Universiteit Rotterdam | Molekularer Nachweis von chromosomalen Veränderungen |
| AU3516899A (en) * | 1998-05-04 | 1999-11-23 | Dako A/S | Method and probes for the detection of chromosome aberrations |
| AUPP655698A0 (en) * | 1998-10-16 | 1998-11-05 | Commonwealth Scientific And Industrial Research Organisation | Delivery system for porcine somatotropin |
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| GB0314856D0 (en) * | 2003-06-25 | 2003-07-30 | Unitargeting Res As | Protein expression system |
| NZ544924A (en) * | 2003-06-27 | 2009-03-31 | Biogen Idec Inc | Modified binding molecules comprising connecting peptides |
| CA2546157C (en) * | 2003-11-21 | 2014-07-22 | Dow Global Technolgies Inc. | Improved expression systems with sec-system secretion |
| NZ550518A (en) * | 2004-03-23 | 2009-11-27 | Biogen Idec Inc | Agents that cross link TNF receptors for treating cancer |
| BRPI0513826A2 (pt) | 2004-07-26 | 2010-06-22 | Dow Global Technologies Inc | processo para expressão de proteìna melhorada através de engenharia de cepa |
| WO2006074399A2 (en) * | 2005-01-05 | 2006-07-13 | Biogen Idec Ma Inc. | Multispecific binding molecules comprising connecting peptides |
| US8338376B2 (en) * | 2006-10-20 | 2012-12-25 | Biogen Idec Ma Inc. | Compositions comprising variant LT-B-R-IG fusion proteins |
| SG154441A1 (en) * | 2006-10-20 | 2009-08-28 | Biogen Idec Inc | Treatment of demyelinating disorders |
| KR20170012582A (ko) | 2006-11-02 | 2017-02-02 | 악셀레론 파마 인코포레이티드 | Ａｌｋ１ 수용체 및 리간드 길항제 및 그의 용도 |
| CA2677179C (en) | 2007-01-31 | 2016-02-16 | Dow Global Technologies Inc. | Bacterial leader sequences for increased expression |
| US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| EP2142651B1 (de) | 2007-04-27 | 2013-05-22 | Pfenex Inc. | Schnellscreeningverfahren für bakterienwirte zur identifizierung bestimmter stämme mit verbessertem ertrag und/oder verbesserter qualität bei der expression heterologer proteine |
| US20110020830A1 (en) * | 2008-03-31 | 2011-01-27 | Schneider Jane C | Design for rapidly cloning one or more polypeptide chains into an expression system |
| AU2009241755B2 (en) | 2008-05-02 | 2015-10-01 | Acceleron Pharma Inc. | Methods and compositions based on ALK1 antagonists for modulating angiogenesis and pericyte coverage |
| JP2010183885A (ja) * | 2009-02-13 | 2010-08-26 | Kobe Univ | タンパク質の製造方法およびそれに用いる発現ベクター |
| CA2833747C (en) | 2011-04-20 | 2022-10-18 | Asya Grinberg | Endoglin polypeptides and uses thereof |
| BR112014019151A2 (pt) | 2012-02-02 | 2017-06-27 | Acceleron Pharma Inc | antagonistas alk1 e seus usos no tratamento de carcinoma de célula renal |
| CA2904978A1 (en) | 2013-03-12 | 2014-10-09 | The General Hospital Corporation | Modified mullerian inhibiting substance (mis) proteins and uses thereof for the treatment of diseases |
| AU2014308751B2 (en) | 2013-08-22 | 2020-03-05 | Acceleron Pharma, Inc. | TGF-beta receptor type II variants and uses thereof |
| EP3851118A1 (de) | 2013-10-25 | 2021-07-21 | Acceleron Pharma Inc. | Endoglinpeptide zur behandlung fibrotischer erkrankungen |
| CA3151082A1 (en) | 2013-12-11 | 2015-06-18 | The General Hospital Corporation | Use of mullerian inhibiting substance (mis) proteins for contraception and ovarian reserve preservation |
| JP7320350B2 (ja) | 2015-08-04 | 2023-08-03 | アクセルロン ファーマ インコーポレイテッド | 骨髄増殖性障害を処置するための方法 |
| PL3628049T3 (pl) | 2017-05-04 | 2023-09-25 | Acceleron Pharma Inc. | Białka fuzyjne receptora TGF-beta typu II i ich zastosowania |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4411994A (en) * | 1978-06-08 | 1983-10-25 | The President And Fellows Of Harvard College | Protein synthesis |
| US4338397A (en) * | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
| US4546082A (en) * | 1982-06-17 | 1985-10-08 | Regents Of The Univ. Of California | E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins |
| DE3382547D1 (de) * | 1983-01-12 | 1992-05-27 | Chiron Corp | Sekretorische expression in eukaryoten. |
| ATE95236T1 (de) * | 1983-04-25 | 1993-10-15 | Chiron Corp | Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren. |
| US4588684A (en) * | 1983-04-26 | 1986-05-13 | Chiron Corporation | a-Factor and its processing signals |
| IL71991A (en) * | 1983-06-06 | 1994-05-30 | Genentech Inc | Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes |
| FR2579224B1 (fr) * | 1985-03-25 | 1987-05-22 | Genetica | Procede de preparation microbiologique de la serum-albumine humaine |
-
1985
- 1985-11-25 GB GB858529014A patent/GB8529014D0/en active Pending
-
1986
- 1986-11-24 WO PCT/EP1986/000675 patent/WO1987003300A1/en active IP Right Grant
- 1986-11-24 JP JP61506239A patent/JP2528849B2/ja not_active Expired - Lifetime
- 1986-11-24 EP EP86906826A patent/EP0283475B1/de not_active Expired - Lifetime
- 1986-11-24 DE DE3689846T patent/DE3689846T2/de not_active Expired - Lifetime
- 1986-11-24 CA CA000523697A patent/CA1318617C/en not_active Expired - Lifetime
- 1986-11-24 AT AT86906826T patent/ATE105865T1/de not_active IP Right Cessation
-
1989
- 1989-12-18 US US07/452,632 patent/US5082783A/en not_active Expired - Lifetime
-
1994
- 1994-12-07 JP JP6303910A patent/JP2572952B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB8529014D0 (en) | 1986-01-02 |
| JP2572952B2 (ja) | 1997-01-16 |
| EP0283475A1 (de) | 1988-09-28 |
| US5082783A (en) | 1992-01-21 |
| DE3689846D1 (de) | 1994-06-23 |
| EP0283475B1 (de) | 1994-05-18 |
| WO1987003300A1 (en) | 1987-06-04 |
| CA1318617C (en) | 1993-06-01 |
| JPH07222595A (ja) | 1995-08-22 |
| JPS63502717A (ja) | 1988-10-13 |
| DE3689846T2 (de) | 1994-09-22 |
| JP2528849B2 (ja) | 1996-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE105865T1 (de) | Erhöhte ausscheidung von heterologen proteinen durch wirtszellen durch verwendung von substituierten promotoren. | |
| KR860008285A (ko) | 심방의 나트륨 이뇨성/혈관 확장성 폴리펩티드의 제조방법 | |
| IE811463L (en) | Interferons | |
| ES551913A0 (es) | Un metodo para obtener expresion de una secuencia de codificacion deseada en celulas de mamifero | |
| DE3786321D1 (de) | Expression von protein-c. | |
| ATE63757T1 (de) | Expression durch verwendung von fusionsgenen fuer proteinproduktion. | |
| DK84194A (da) | Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn | |
| KR920012442A (ko) | 피치아 파스토리스 산성 인산효소 유전자의 dna 단편 및 이를 사용하는 방법 | |
| Carter | Interferon: evidence for subunit structure | |
| FI885679A (fi) | Samuttryckning i eukariotiska celler. | |
| FI922204A (fi) | Proteinkomplex med faktor viii:c- aktivitet och framstaellning av desamma. | |
| ATE109830T1 (de) | Expression von virusproteinen mit immunologischer aktivität. | |
| DE3688900T3 (de) | Expression von Protein C. | |
| DE69132814T2 (de) | Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5 | |
| Smith et al. | Characterization of collagen synthesized by normal and chemically transformed rat liver epithelial cell lines | |
| KR840008697A (ko) | 상동 효모 신호를 이용한 이종단백질의 합성, 분비 및 표현매개체 제조방법 | |
| EP0232107A3 (de) | Derivat des menschlichen Lymphotoxin-Polypeptids | |
| EP0072541A3 (de) | Menschliche Leukozyten-Interferone, Verfahren zu deren Mikrobiologischer Herstellung, Zwischenprodukte und diese enthaltende Zusammensetzungen | |
| KR870006185A (ko) | 트롬빈 억제제의 제조방법 | |
| GB2314332A (en) | Gene expression in mammalian cells | |
| RU93004936A (ru) | Днк, штаммы, способы получения днк, способы получения полипептидов | |
| FI934079A (fi) | Menetelmä fuusioproteiinin valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |